We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock
DMTK

Delisted

DMTK was delisted on the 26th of June, 2024.

Back to rankings

22 hedge funds and large institutions have $65.6M invested in DermTech, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 1

144% more funds holding

Funds holding: 9 → 22 (+13)

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

47% more capital invested

Capital invested by funds: $44.7M → $65.6M (+$21M)

Holders
22
Holders Change
+13
Holders Change %
+144.44%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
4
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
+$7.02M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$4.09M
3
PVI
Pura Vida Investments
New York
+$3.79M
4
PA
Perceptive Advisors
New York
+$3.51M
5
MS
Maven Securities
Jersey
+$2.64M

Top Sellers

Rank Fund Capital Flow
1
CC
Centiva Capital
New York
-$151K
2
FCM
Farallon Capital Management
California
-$124K
3
UBS Group
UBS Group
Switzerland
-$5.54K

DMTK Hedge Fund Activity: Q1 2020 in Review

22 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q1 2020, worth a combined $65.6M — up 47% from $44.7M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new DMTK positions and 1 closed out — a net gain of 14 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Casdin Capital, opening a new position worth an estimated $7.02M. The largest seller was Centiva Capital, exiting entirely with an estimated $151K sold.

  • 22 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q1 2020, up from 9 in Q4 2019.
  • Funds reported $65.6M of DermTech, Inc. Common Stock stock for Q1 2020, up 47% quarter-over-quarter.
  • 15 funds opened new DermTech, Inc. Common Stock positions in Q1 2020 and 1 closed out, a net change of +14 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q1 2020 was Casdin Capital, an estimated $7.02M added.
  • The largest DermTech, Inc. Common Stock seller in Q1 2020 was Centiva Capital, an estimated $151K sold.

Based on aggregated 13F filings for Q1 2020.